| Scrip Code | 544558 |
|---|---|
| NSE Symbol | FABTECH |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0HF201011 |
| Name of company | Fabtech Technologies Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 27-10-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 23-10-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Half Yearly |
| Reporting Quarter | Half yearly |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Segment Reporting | Geographical |
| Description of single segment | |
| Start date and time of board meeting | 27-10-2025 04:00:00 |
| End date and time of board meeting | 27-10-2025 23:00:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 18,948.75 | 18,948.75 | |
| Other income | 374.05 | 374.05 | |
| Total income | 19,322.80 | 19,322.80 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 7,639.23 | 7,639.23 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 2,204.11 | 2,204.11 |
| (d) | Employee benefit expense | 1,954.91 | 1,954.91 |
| (e) | Finance costs | 240.87 | 240.87 |
| (f) | Depreciation, depletion and amortisation expense | 270.08 | 270.08 |
| (f) | Other Expenses | ||
| 1 | Project erection and commissioning expenses | 1,249.77 | 1,249.77 |
| 2 | Business Promotion and Advertising | 400.90 | 400.90 |
| 3 | Travelling and Conveyance expenses | 616.32 | 616.32 |
| 4 | Freight and forwarding | 1,621.39 | 1,621.39 |
| 5 | Provision for Doubtful Debt and advances | 209.92 | 209.92 |
| 6 | Legal and professional charges | 195.21 | 195.21 |
| 7 | Rent | 145.00 | 145.00 |
| 8 | Bank Charges | 61.87 | 61.87 |
| 9 | Communication Expenses | 52.68 | 52.68 |
| 10 | Other Expenses | 173.27 | 173.27 |
| Total other expenses | 4,726.33 | 4,726.33 | |
| Total expenses | 17,035.53 | 17,035.53 | |
| 3 | Total profit before exceptional items and tax | 2,287.27 | 2,287.27 |
| 4 | Exceptional items | 177.49 | 177.49 |
| 5 | Total profit before tax | 2,464.76 | 2,464.76 |
| 6 | Tax expense | ||
| 7 | Current tax | 456.68 | 456.68 |
| 8 | Deferred tax | (148.17) | (148.17) |
| 9 | Total tax expenses | 308.51 | 308.51 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 2,156.25 | 2,156.25 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 41.77 | 41.77 |
| 16 | Total profit (loss) for period | 2,198.02 | 2,198.02 |
| 17 | Other comprehensive income net of taxes | (6.73) | (6.73) |
| 18 | Total Comprehensive Income for the period | 2,191.29 | 2,191.29 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 2,198.02 | 2,198.02 | |
| Total profit or loss, attributable to non-controlling interests | 0.01 | 0.01 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | (6.73) | (6.73) | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 2,191.29 | 2,191.29 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 3,239.22 | 3,239.22 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 6.79 | 6.79 | |
| Diluted earnings (loss) per share from continuing operations | 6.79 | 6.79 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 6.79 | 6.79 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 6.79 | 6.79 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | 1.The consolidated financial results of Fabtech Technologies Limited (the Company) has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 (theAct) and other accounting principles generally accepted in India and presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, (Listing Regulations) These results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on October 27, 2025. In compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Limited review of the consolidated results of quarter and half year ended September 30, 2025 has been carried out by the Statutory Auditors. 2.Previous Year's/Period's figures have been regrouped/rearranged/adjusted/rectified wherever considered necessary. 3.The figures for the year ended March 31, 2025 have been extracted from the consolidated financial statements which were audited by the Statutory Auditors of the Company. The figures for the corresponding quarter and half year ended September 30, 2024 and have not been subjected to a review or audit by the Statutory Auditors, However, the management has exercised necessary care to ensure that the standalone financial results for that period are fairly stated. These figures are furnished by the mangement of the Company and were reviewed and recommended by the Audit committee and approved by the Board of Directors at their meeting held on October 27, 2025. 4.Subsequent to the quarter ended September 30, 2025, the Company has completed its initial public offer (IPO) of fresh issue of 1,20,60,000 equity shares of face value of Rs.10 each at an issue price of Rs.191. The equity shares of the Company were listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on October 7, 2025. The Company will provide an update on the utilisation of IPO proceeds towards the objects of the fresh issue effective from next reporting period based on actual utilisation of the funds pursuant to the IPO. 5.The reportable segments derives their revenues from turnkey projects solution provided to pharmaceuticals and allied industries by way of supplying pharmaceutical machineries / equipment,inhouse designing and engineering and to undertake other activities requiredinvarious pharmaceutical turnkeyprojects. The CODM reviews geographical revenue as the performance indicator. The measurement of geographical segment’s revenues and assets is consistent with the accounting policies that are used in preparation of the Group’s Consolidated Financial Results. The same is attached herewith as Annexure A to the Unaudited Consolidated Financial Results. 6.The exceptional item amounting to Rs. 177.49 Lakhs disclosed in the profit or loss statement for the half year ended September 30, 2025 and quarter ended June 30, 2025, represents the profit arising from the sale of 51% stake in the subsidiary LLP. Prior to the transaction, the Company held 99.99% ownership interest in the Subsidiary LLP. Post Sale, the Company's ownership interest has reduced to 48.99%. This transaction is significant and non-recurring in nature and has been presented separately as an exceptional item to provide clarity and transparency to the users of the financial results. 7.The exceptional item amounting to Rs. 1,784.86 Lakhs disclosed in the Statement of Profit and Loss for the quarter ended June 30, 2024, represents the profit arising from the sale of a equity stake in the associate. Prior to this transaction, the Company held a 33.33% ownership interest in the associate. Post-sale, the Company’s ownership has reduced to 16.33%, which has been classified as “Asset Held for Sale” as disclosed in the audited financial statements for the year ended March 31, 2025. This transaction is significant and non-recurring in nature and has therefore been presented separately as an exceptional item to ensure greater clarity and transparency for users of the financial statements. 8.The unaudited consolidated financial results are also being made available on the Stock Exchange websites www.bseindia.com and www.nseindia.com and on the Company's website: www.fabtechnologies.com. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 2,868.13 | ||
| Capital work-in-progress | |||
| Investment property | |||
| Goodwill | 2,220.97 | ||
| Other intangible assets | 54.99 | ||
| Intangible assets under development | |||
| Biological assets other than bearer plants | |||
| Investments accounted for using equity method | |||
| Non-current financial assets | |||
| Non-current investments | 1,594.84 | ||
| Trade receivables, non-current | |||
| Loans, non-current | 848.55 | ||
| Other non-current financial assets | 613.31 | ||
| Total non-current financial assets | 3,056.70 | ||
| Deferred tax assets (net) | 310.16 | ||
| Other non-current assets | 2,755.78 | ||
| Total non-current assets | 11,266.73 | ||
| 2 | Current assets | ||
| Inventories | 2,551.93 | ||
| Current financial asset | |||
| Current investments | 946.49 | ||
| Trade receivables, current | 15,465.54 | ||
| Cash and cash equivalents | 2,217.01 | ||
| Bank balance other than cash and cash equivalents | 1,929.02 | ||
| Loans, current | 19.68 | ||
| Other current financial assets | 1,978.11 | ||
| Total current financial assets | 22,555.85 | ||
| Current tax assets (net) | 0.00 | ||
| Other current assets | 4,813.08 | ||
| Total current assets | 29,920.86 | ||
| 3 | Non-current assets classified as held for sale | 563.35 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 | |
| Total assets | 41,750.94 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 3,239.22 | ||
| Other equity | 16,244.11 | ||
| Total equity attributable to owners of parent | 19,483.33 | ||
| Non controlling interest | (0.01) | ||
| Total equity | 19,483.32 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 37.84 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | |||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | |||
| Total Trade payable | |||
| Other non-current financial liabilities | 2,592.98 | ||
| Total non-current financial liabilities | 2,630.82 | ||
| Provisions, non-current | 152.83 | ||
| Deferred tax liabilities (net) | |||
| Deferred government grants, Non-current | |||
| Other non-current liabilities | |||
| Total non-current liabilities | 2,783.65 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 1,401.46 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 1,346.45 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 3,623.36 | ||
| Total Trade payable | 4,969.81 | ||
| Other current financial liabilities | 876.33 | ||
| Total current financial liabilities | 7,247.60 | ||
| Other current liabilities | 11,828.22 | ||
| Provisions, current | 74.38 | ||
| Current tax liabilities (Net) | 333.77 | ||
| Deferred government grants, Current | |||
| Total current liabilities | 19,483.97 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | ||
| 4 | Regulatory deferral account credit balances and related deferred tax liability | ||
| Total liabilities | 22,267.62 | ||
| Total equity and liabilites | 41,750.94 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
| Textual Information(1) | Rs. 2592.98 of lease liabilites (non- current) is disclosed under the head other non current financial liablities. Rs 180 of lease liabilites (current) is clubbed with Rs.696.33 of Other financial liablities under the head Other current financial liabilities amount to Rs |
|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | UAE | 8,742.42 | 8,742.42 | ||||
| 2 | Saudi Arabia | 3,901.05 | 3,901.05 | ||||
| 3 | Egypt | 0.00634 | 0.00634 | ||||
| 4 | India | 1,924.60 | 1,924.60 | ||||
| 5 | Sri Lanka | 0.0005908 | 0.0005908 | ||||
| 6 | Algeria | 0.0025962 | 0.0025962 | ||||
| 7 | Kenya | 0.0027272 | 0.0027272 | ||||
| 8 | Rest of the World | 6,100.32 | 6,100.32 | ||||
| Total Segment Revenue | 21,893.81 | 21,893.81 | |||||
| Less: Inter segment revenue | 2,945.06 | 2,945.06 | |||||
| Revenue from operations | 18,948.75 | 18,948.75 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | UAE | 0.00 | 0.00 | ||||
| 2 | Saudi Arabia | 0.00 | 0.00 | ||||
| 3 | Egypt | 0.00 | 0.00 | ||||
| 4 | India | 0.00 | 0.00 | ||||
| 5 | Sri Lanka | 0.00 | 0.00 | ||||
| 6 | Algeria | 0.00 | 0.00 | ||||
| 7 | Kenya | 0.00 | 0.00 | ||||
| 8 | Rest of the World | 0.00 | 0.00 | ||||
| Total Profit before tax | 0.00 | 0.00 | |||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | 0.00 | 0.00 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | UAE | 1,772.36 | 1,772.36 | ||||
| 2 | Saudi Arabia | 4,686.60 | 4,686.60 | ||||
| 3 | Egypt | 119.68 | 119.68 | ||||
| 4 | India | 2,456.08 | 2,456.08 | ||||
| 5 | Sri Lanka | 349.04 | 349.04 | ||||
| 6 | Algeria | 326.24 | 326.24 | ||||
| 7 | Kenya | 286.20 | 286.20 | ||||
| 8 | Rest of the World | 5,849.62 | 5,849.62 | ||||
| Total Segment Asset | 15,845.82 | 15,845.82 | |||||
| Un-allocable Assets | 0.00 | 0.00 | |||||
| Net Segment Asset | 15,845.82 | 15,845.82 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | UAE | 0.00 | 0.00 | ||||
| 2 | Saudi Arabia | 0.00 | 0.00 | ||||
| 3 | Egypt | 0.00 | 0.00 | ||||
| 4 | India | 0.00 | 0.00 | ||||
| 5 | Sri Lanka | 0.00 | 0.00 | ||||
| 6 | Algeria | 0.00 | 0.00 | ||||
| 7 | Kenya | 0.00 | 0.00 | ||||
| 8 | Rest of the World | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 0.00 | 0.00 | |||||
| Un-allocable Liabilities | 0.00 | 0.00 | |||||
| Net Segment Liabilities | 0.00 | 0.00 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined benefit plans | (9.00) | (9.00) |
| Total Amount of items that will not be reclassified to profit and loss | (9.00) | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (2.27) | (2.27) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | (6.73) | (6.73) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | ||||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 240.51 | |||||
| Adjustments for decrease (increase) in inventories | 3,389.66 | |||||
| Adjustments for decrease (increase) in trade receivables, current | (658.33) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (2,927.66) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 1,188.80 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (4,920.71) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 5,533.15 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 270.08 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 57.84 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 668.01 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 45.49 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 140.33 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | (30.40) | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | (0.11) | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 22.67 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 2,738.67 | |||||
| Net cash flows from (used in) operations | 5,203.43 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 714.12 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 4,489.31 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 935.48 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 273.53 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.11 | |||||
| Purchase of property, plant and equipment | 234.92 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 135.30 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 670.43 | |||||
| Net cash flows from (used in) investing activities | 1,232.87 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | (4,022.75) | |||||
| Repayments of borrowings | 0.00 | |||||
| Payments of lease liabilities | 274.56 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (113.42) | |||||
| Net cash flows from (used in) financing activities | (4,410.73) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 1,311.45 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 1,311.45 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 905.56 | |||||
| Cash and cash equivalents cash flow statement at end of period | 2,217.01 | |||||